Affordable Access

deepdyve-link
Publisher Website

Vitamin D, magnesium, calcium, and their interaction in relation to colorectal cancer recurrence and all-cause mortality

Authors
  • Wesselink, Evertine1
  • Kok, Dieuwertje E1
  • Bours, Martijn J L2
  • de Wilt, Johannes H W3
  • van Baar, Harm1
  • van Zutphen, Moniek1
  • Geijsen, Anne M J R1
  • Keulen, Eric T P4
  • Hansson, Bibi M E5
  • van den Ouweland, Jody6
  • Witkamp, Renger F1
  • Weijenberg, Matty P2
  • Kampman, Ellen1
  • van Duijnhoven, Fränzel J B1
  • 1 Division of Human Nutrition and Health, Wageningen University & Research, Netherlands , (Netherlands)
  • 2 Department of Epidemiology, GROW-School for Oncology and Developmental Biology, Maastricht University, Netherlands , (Netherlands)
  • 3 Department of Surgery, Radboud University Medical Centre, Netherlands , (Netherlands)
  • 4 Department of Gastroenterology, Zuyderland Medical Centre, Netherlands , (Netherlands)
  • 5 Department of Surgery, Canisius-Wilhelmina Hospital, Netherlands , (Netherlands)
  • 6 Department of Clinical Chemistry, Canisius-Wilhelmina Hospital, Netherlands , (Netherlands)
Type
Published Article
Journal
American Journal of Clinical Nutrition
Publisher
Oxford University Press
Publication Date
Mar 19, 2020
Volume
111
Issue
5
Pages
1007–1017
Identifiers
DOI: 10.1093/ajcn/nqaa049
PMID: 32190892
PMCID: PMC7198285
Source
PubMed Central
Keywords
License
Unknown

Abstract

Background Higher concentrations of 25-hydroxyvitamin D3 [25(OH)D3] at diagnosis are associated with a lower mortality risk in colorectal cancer (CRC) patients. However, magnesium and calcium are important in vitamin D metabolism. Objectives We aimed to investigate 25(OH)D3, magnesium, or calcium and their interaction among patients with CRC in relation to recurrence and all-cause mortality. Methods The study population included 1169 newly diagnosed stage I–III CRC patients from 2 prospective cohorts. Associations between 25(OH)D3 concentrations, magnesium or calcium intake through diet and/or supplements at diagnosis, and recurrence and all-cause mortality were evaluated using multivariable Cox proportional hazard models. The interaction between 25(OH)D3 and magnesium or calcium was assessed by investigating 1 ) joint compared with separate effects, using a single reference category; and 2 ) the effect estimates of 1 factor across strata of another. Results Serum 25(OH)D3, calcium, and magnesium, alone and their interactions, were not associated with recurrence. Serum 25(OH)D3 concentrations seemed to be associated with all-cause mortality. An inverse association between magnesium intake (HRQ3 vs. Q1: 0.55; 95% CI: 0.32, 0.95 and HRQ4 vs. Q1: 0.65; 95% CI: 0.35, 1.21), but not calcium intake, and all-cause mortality was observed. When investigating the interaction between 25(OH)D3 and magnesium, we observed the lowest risk of all-cause mortality in patients with sufficient vitamin D concentrations (≥50 nmol/L) and a high magnesium intake (median split) (HR: 0.53; 95% CI: 0.31, 0.89) compared with patients who were vitamin D deficient (<50 nmol/L) and had a low magnesium intake. No interactions between calcium and vitamin D in relation to all-cause mortality were observed. Conclusions Our findings suggest that the presence of an adequate status of 25(OH)D3 in combination with an adequate magnesium intake is essential in lowering the risk of mortality in CRC patients, yet the underlying mechanism should be studied. In addition, diet and lifestyle intervention studies are needed to confirm our findings. The COLON study was registered at clinicaltrials.gov as NCT03191110. The EnCoRe study was registered at trialregister.nl as NTR7099.

Report this publication

Statistics

Seen <100 times